Evidence map›Paper›PMID 23107152›Full record

ArticleThe Journal of allergy and clinical immunology2013

Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia.

Masaki Shimizu, Hirokazu Kanegane, Taizo Wada, Yaeko Motoyoshi, Tomohiro Morio, Fabio Candotti, Akihiro Yachie

Abstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Advances in basic and clinical immunology in 2013.The Journal of allergy and clinical immunology · 2014
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Masaki Shimizu
Hirokazu Kanegane
Taizo Wada
Yaeko Motoyoshi
Tomohiro Morio
Fabio Candotti
Akihiro Yachie
Kanazawa University · JPTokyo Medical and Dental University · JPNational Institutes of Health · USUniversity of Toyama · JP

Funding

Gene Therapy Approaches for Primary ImmunodeficienciesZIAHG000122 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI CANDOTTI, FABIO · 2009 to 2014
$6.5M
Molecular and Clinical Studies of Primary ImmunodeficienciesZIAHG000121 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI CANDOTTI, FABIO · 2009 to 2014
$6.2M
GENE THERAPY APPROACHES FOR PRIMARY IMMUNODEFICIENCIESZ01HG000122 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI CANDOTTI, FABIO · 1998 to 2008
$3.2M
Intramural NIH HHS Z01 HG000122
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultCase-Control StudiesChildChild, PreschoolCohort StudiesFemaleGalactoseGenetic Diseases, X-LinkedGlomerulonephritisGlycosylationHumansImmunoglobulin AInfantMaleRetrospective StudiesGalactoseImmunoglobulin A

Identifiers

PMID23107152
PMCPMC3563712
OpenAlexW2165561986

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.